HealthTech & BioTech


iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery & development. Through advanced AI & photonics, we collect massive amounts of data to build a digital library of biomarkers & biological profiles, bringing together world-class physicists, biologists, & data scientists to get life-saving personalized treatments to patients faster. Our technology detects label-free nanosized biomarkers in biological liquid samples, to generate specific patient or disease signatures.

Industry domain

Digital Health

Investment stage and needs

At the Seed Stage, they raised $5M in 2022. They aim to raise a Series A ($$M) in 2024 with a specialized lead focused on Health Tech and AI/ML Startups. Their current needs include accessing industry experts and mentors to ensure successful market penetration, setting a winning strategy for navigating and thriving in global expansion, and achieving sustainable growth.

Pitch deck

The X2.0 Acceleration Program


Luis Valente
CEO & Co-Founder
Mehak Mumtaz
COO & Co-Founder

Would you like to be an Impact Builder?